247 related articles for article (PubMed ID: 18305408)
1. Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation.
Ostenfeld MS; Høyer-Hansen M; Bastholm L; Fehrenbacher N; Olsen OD; Groth-Pedersen L; Puustinen P; Kirkegaard-Sørensen T; Nylandsted J; Farkas T; Jäättelä M
Autophagy; 2008 May; 4(4):487-99. PubMed ID: 18305408
[TBL] [Abstract][Full Text] [Related]
2. Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes.
Česen MH; Repnik U; Turk V; Turk B
Cell Death Dis; 2013 Oct; 4(10):e818. PubMed ID: 24091661
[TBL] [Abstract][Full Text] [Related]
3. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress.
Ostenfeld MS; Fehrenbacher N; Høyer-Hansen M; Thomsen C; Farkas T; Jäättelä M
Cancer Res; 2005 Oct; 65(19):8975-83. PubMed ID: 16204071
[TBL] [Abstract][Full Text] [Related]
4. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine.
Groth-Pedersen L; Ostenfeld MS; Høyer-Hansen M; Nylandsted J; Jäättelä M
Cancer Res; 2007 Mar; 67(5):2217-25. PubMed ID: 17332352
[TBL] [Abstract][Full Text] [Related]
5. Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
Jensen SS; Petterson SA; Halle B; Aaberg-Jessen C; Kristensen BW
BMC Cancer; 2017 Mar; 17(1):178. PubMed ID: 28270132
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.
Ma S; Henson ES; Chen Y; Gibson SB
Cell Death Dis; 2016 Jul; 7(7):e2307. PubMed ID: 27441659
[TBL] [Abstract][Full Text] [Related]
7. Dependence of glucose transport on autophagy and GAPDH activity.
Craven RJ; Frazier HN; Thibault O
Brain Res; 2022 Feb; 1776():147747. PubMed ID: 34864044
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1 signaling.
Valapala M; Wilson C; Hose S; Bhutto IA; Grebe R; Dong A; Greenbaum S; Gu L; Sengupta S; Cano M; Hackett S; Xu G; Lutty GA; Dong L; Sergeev Y; Handa JT; Campochiaro P; Wawrousek E; Zigler JS; Sinha D
Autophagy; 2014 Mar; 10(3):480-96. PubMed ID: 24468901
[TBL] [Abstract][Full Text] [Related]
9. AMPK Inhibits ULK1-Dependent Autophagosome Formation and Lysosomal Acidification via Distinct Mechanisms.
Nwadike C; Williamson LE; Gallagher LE; Guan JL; Chan EYW
Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29507183
[TBL] [Abstract][Full Text] [Related]
10. Two pore channel 2 (TPC2) inhibits autophagosomal-lysosomal fusion by alkalinizing lysosomal pH.
Lu Y; Hao BX; Graeff R; Wong CW; Wu WT; Yue J
J Biol Chem; 2013 Aug; 288(33):24247-63. PubMed ID: 23836916
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of autophagosomes confers cytotoxicity.
Button RW; Roberts SL; Willis TL; Hanemann CO; Luo S
J Biol Chem; 2017 Aug; 292(33):13599-13614. PubMed ID: 28673965
[TBL] [Abstract][Full Text] [Related]
12. Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A.
Lu Y; Dong S; Hao B; Li C; Zhu K; Guo W; Wang Q; Cheung KH; Wong CW; Wu WT; Markus H; Yue J
Autophagy; 2014; 10(11):1895-905. PubMed ID: 25483964
[TBL] [Abstract][Full Text] [Related]
13. The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.
Gutierrez E; Richardson DR; Jansson PJ
J Biol Chem; 2014 Nov; 289(48):33568-89. PubMed ID: 25301941
[TBL] [Abstract][Full Text] [Related]
14. Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death.
Kondratskyi A; Yassine M; Slomianny C; Kondratska K; Gordienko D; Dewailly E; Lehen'kyi V; Skryma R; Prevarskaya N
Cell Death Dis; 2014 Apr; 5(4):e1193. PubMed ID: 24763050
[TBL] [Abstract][Full Text] [Related]
15. Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth.
Azoulay-Alfaguter I; Elya R; Avrahami L; Katz A; Eldar-Finkelman H
Oncogene; 2015 Aug; 34(35):4613-23. PubMed ID: 25500539
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal positioning coordinates cellular nutrient responses.
Korolchuk VI; Saiki S; Lichtenberg M; Siddiqi FH; Roberts EA; Imarisio S; Jahreiss L; Sarkar S; Futter M; Menzies FM; O'Kane CJ; Deretic V; Rubinsztein DC
Nat Cell Biol; 2011 Apr; 13(4):453-60. PubMed ID: 21394080
[TBL] [Abstract][Full Text] [Related]
17. IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo.
Guntuku L; Gangasani JK; Thummuri D; Borkar RM; Manavathi B; Ragampeta S; Vaidya JR; Sistla R; Vegi NGM
Oncogene; 2019 Jan; 38(4):581-595. PubMed ID: 30166591
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of the sigma-2 receptor agonist siramesine on lysosomal and extra-lysosomal proteolytic systems in lens epithelial cells.
Jonhede S; Petersen A; Zetterberg M; Karlsson JO
Mol Vis; 2010 May; 16():819-27. PubMed ID: 20461150
[TBL] [Abstract][Full Text] [Related]
19. The formation of autophagosomes during lysosomal defect: A new source of cytotoxicity.
Button RW; Luo S
Autophagy; 2017 Oct; 13(10):1797-1798. PubMed ID: 28820297
[TBL] [Abstract][Full Text] [Related]
20. Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism.
Dielschneider RF; Eisenstat H; Mi S; Curtis JM; Xiao W; Johnston JB; Gibson SB
Leukemia; 2016 Jun; 30(6):1290-300. PubMed ID: 26859075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
